Literature DB >> 18449205

Successful treatment of multicentric Castleman's disease with combined immunochemotherapy in an AIDS patient with multiorgan failure.

S M Schmidt, A Raible, F Kortüm, F Mayer, R Riessen, P Adam, M Gregor, A L Bissinger.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18449205     DOI： 10.1038/leu.2008.54

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.

Authors:  Deboeeta Chatterjee; Bala Chandran; Edward A Berger
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report.

Authors:  Robin H Johns; Tomas Doyle; Marc C Lipman; Kate Cwynarski; Joanne R Cleverley; Peter G Isaacson; Steve Shaw; Banwari Agarwal
Journal:  J Med Case Rep       Date:  2010-01-30

Review 3.  HIV-associated multicentric Castleman disease.

Authors:  Deepa Reddy; Ronald Mitsuyasu
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

4.  Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Denise Whitby; Victoria Wang; Stefania Pittaluga; Deirdre O'Mahony; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

5.  Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A.

Authors:  Kristen M Tamburro; Dongmei Yang; Jessica Poisson; Yuri Fedoriw; Debasmita Roy; Amy Lucas; Sang-Hoon Sin; Nadia Malouf; Vincent Moylan; Blossom Damania; Stephan Moll; Charles van der Horst; Dirk P Dittmer
Journal:  Virology       Date:  2012-08-24       Impact factor: 3.616

6.  An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection.

Authors:  Yingyun Cai; Edward A Berger
Journal:  Antiviral Res       Date:  2011-03-31       Impact factor: 10.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.